CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

Source:http://linkedlifedata.com/resource/pubmed/id/8674060

Cancer Res. 1996 Jul 1 56 13 3042-6

Download in:

View as

General Info

PMID
8674060